Nutex Health Inc. (NUTX)
NASDAQ: NUTX
· Real-Time Price · USD
93.55
-2.63 (-2.73%)
At close: Aug 22, 2025, 1:44 PM
Nutex Health Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 44.22M | 99.97M | -7.17M | 3.01M | -542K | -27.71M | -4.52M | -4.27M | -6.92M | -327.05K | -422.91M | -24M | 24.83M | 13.65M | 74.49M | 85.04M | -4.48M |
Depreciation & Amortization | 5.09M | 5.28M | 4.97M | 4.53M | 4.19M | 4.68M | 4.75M | 4.17M | 3.99M | 3.27M | 4.33M | 3.13M | 2.4M | 1.79M | 1.87M | 3.94M | 65.1K |
Stock-Based Compensation | 36.09M | 14.68M | 1.96M | -61.07K | 49K | 637.16K | 49.17K | 249.65K | 1.9M | 54.17K | 81.25K | 54.17K | n/a | n/a | n/a | -3.85M | 3.85M |
Other Working Capital | 19.8M | 63.85M | 6.55M | 3.34M | 5.45M | 1.28M | 1.18M | -2.2M | 4.77M | 215.73K | -10.59M | 7.24M | 403.55K | 2.97M | -256.25K | 1.45M | 21.41K |
Other Non-Cash Items | 253K | 662.33K | 7.31M | 4.07M | -2.24M | 30.22M | 326.23K | 967.69K | 105.49K | -9.49M | 398.52M | 1.29M | 58.86K | 562.56K | -602.75K | -5.15M | 476.62K |
Deferred Income Tax | -2.5M | -11.39M | 598.47K | -2.25M | -95K | -3.64M | -344.42K | -813.45K | -910.66K | 1.62M | -8.64M | 12.01M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -32.2M | -109.15M | -891.98K | 3.95M | 1.69M | -5.97M | 1.72M | -294.27K | 2.89M | 9.38M | 21.31M | 25.17M | 8.46M | 30.73M | -51.51M | 23.34M | -477.28K |
Operating Cash Flow | 50.97M | 53.46K | 6.79M | 13.26M | 3.05M | -1.78M | 1.97M | 12.32K | 1.05M | 4.51M | -7.3M | 55.78M | -2.38M | 46.74M | 23.94M | 103.32M | -567.06K |
Capital Expenditures | -64K | -395.25K | -617.16K | -558.49K | -733K | 825.65K | -2.88M | -3.07M | -4.38M | 7.88M | -5.89M | -8.03M | -8.59M | -11.84M | -3.49M | -21.71M | n/a |
Cash Acquisitions | n/a | n/a | 349.98K | -711.31K | n/a | 39.94K | -743.84K | n/a | -1.04M | n/a | n/a | 10.3M | n/a | n/a | n/a | -3.8M | 3.8M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -48.85K | n/a | -85K | 85K |
Investing Cash Flow | -64K | -395.25K | -267.18K | -1.27M | -733K | 865.6K | -3.62M | -3.07M | -5.42M | 7.88M | -5.89M | 2.27M | -8.59M | -11.89M | -3.49M | -25.6M | 3.89M |
Debt Repayment | 552K | -4.17M | -84.39K | -107.94K | -3.04M | -2.68M | -2.63M | 3.5M | 4.45M | -12.59M | 4.26M | 1.44M | 1.3M | 821.99K | -2.81M | -1.5M | 393.32K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -7.36M | -2.78M | -1.8M | -1.38M | -481K | -879.05K | -1.65M | -1.15M | -1.54M | -1.26M | -2.14M | -14.98M | -32.85M | -42.65M | -23.24M | n/a | n/a |
Other Financial Acitivies | n/a | 3.96M | 1.46M | 300.85K | n/a | -351.52K | n/a | 621.55K | 28K | -899.55K | 94.26K | 5.65M | 3.84M | 8.86M | 1.49M | -67.41M | n/a |
Financial Cash Flow | -6.81M | -2.99M | -420.99K | -1.19M | 5.69M | -3.91M | -4.28M | 2.98M | 2.95M | -14.75M | 2.21M | -7.88M | -27.71M | -32.97M | -24.56M | -68.92M | 393.32K |
Net Cash Flow | 44.09M | -3.33M | 6.1M | 10.8M | 8M | -4.82M | -5.93M | -82.2K | -1.42M | -2.37M | -10.98M | 12.04M | -559.79K | 1.88M | -3.79M | 34.29M | 3.71M |
Free Cash Flow | 50.9M | -341.78K | 6.17M | 12.7M | 2.32M | -950.56K | -907.25K | -3.06M | -3.32M | 12.39M | -13.19M | 9.63M | 27.15M | 34.9M | 20.76M | 81.61M | -567.06K |